A Pilot Study of Tremelimumab With or Without Tissue Cryoablation in Patients With Metastatic Renal Cell Carcinoma
Phase of Trial: Phase 0
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Tremelimumab (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions
- 30 Mar 2016 Planned primary completion date changed from 1 Apr 2021 to 1 Mar 2021 as reported by ClinicalTrials.gov record.
- 30 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 04 Feb 2016 Planned primary completion date changed from 1 Feb 2021 to 1 Apr 2021, according to ClinicalTrials.gov record.